U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264192) titled 'A Study of HS-10518 in Healthy Adult Premenopausal Females in China' on Nov. 16.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HS-10518 in healthy adult premenopausal females in China
Study Start Date: March 11
Study Type: INTERVENTIONAL
Condition:
Infertility, Female
Intervention:
DRUG: HS-10518
During the Dosing Period, four capsules of HS-10518 are administered twice daily at the same time points each day (morning and evening). The capsules should be swallowed whole with approximately 240 mL of water, and fluid intake is restricted within 1 hour be...